Sharyn D Baker

Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs

Hao Li, Denise G. Teotico, Hongwei Wang, 2007, Clinical Cancer Research.

Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Amar Gajjar, Arzu Onar-Thomas, Thomas E Merchant, 2013, Clinical Cancer Research.

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

Christina D Drenberg, R Kiplin Guy, A. Shelat, 2019, Nature Communications.

Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients

Jing Li, Manuel Hidalgo, Alex Sparreboom, 2007, Cancer biology & therapy.

CYP3A phenotyping approach to predict systemic exposure to EGFR tyrosine kinase inhibitors.

Manuel Hidalgo, Ming Zhao, Mats O Karlsson, 2006, Journal of the National Cancer Institute.

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Ming Zhao, Alex Sparreboom, A. Wolff, 2004, Clinical Cancer Research.

Irinotecan pathway genotype analysis to predict pharmacokinetics.

Sharon Marsh, Ron H J Mathijssen, Mats O Karlsson, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.